DK3068437T3 - Sprøjtbar topisk bærer og sammensætning omfattende phosphatidylcholin - Google Patents
Sprøjtbar topisk bærer og sammensætning omfattende phosphatidylcholin Download PDFInfo
- Publication number
- DK3068437T3 DK3068437T3 DK14861615.4T DK14861615T DK3068437T3 DK 3068437 T3 DK3068437 T3 DK 3068437T3 DK 14861615 T DK14861615 T DK 14861615T DK 3068437 T3 DK3068437 T3 DK 3068437T3
- Authority
- DK
- Denmark
- Prior art keywords
- explosible
- phosphatidylcholine
- topic
- carrier
- composition comprehensive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1300710 | 2013-11-14 | ||
PCT/SE2014/051313 WO2015072909A1 (en) | 2013-11-14 | 2014-11-06 | Sprayable topical carrier and composition comprising phosphatidylcholine |
Publications (2)
Publication Number | Publication Date |
---|---|
DK3068437T3 true DK3068437T3 (da) | 2019-09-16 |
DK3068437T4 DK3068437T4 (da) | 2022-09-26 |
Family
ID=53057732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14861615.4T DK3068437T4 (da) | 2013-11-14 | 2014-11-06 | Sprøjtbar topisk bærer og sammensætning omfattende phosphatidylcholin |
Country Status (15)
Country | Link |
---|---|
US (2) | US10034943B2 (da) |
EP (2) | EP3068437B2 (da) |
JP (1) | JP6563922B2 (da) |
KR (1) | KR102297951B1 (da) |
CN (2) | CN112006989A (da) |
AU (1) | AU2014349256B2 (da) |
CA (1) | CA2929865C (da) |
DK (1) | DK3068437T4 (da) |
ES (1) | ES2745093T5 (da) |
HU (1) | HUE045492T2 (da) |
PL (1) | PL3068437T5 (da) |
PT (1) | PT3068437T (da) |
RS (1) | RS59357B2 (da) |
RU (1) | RU2699651C1 (da) |
WO (1) | WO2015072909A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113648278A (zh) * | 2013-05-03 | 2021-11-16 | 立普妥公司 | 用于给药的运载体和局部组合物 |
JP6563922B2 (ja) | 2013-11-14 | 2019-08-21 | リピドール エービー | ホスファチジルコリンを含む噴霧可能な局部用キャリアー及び組成物 |
WO2019224035A1 (en) * | 2018-05-24 | 2019-11-28 | Almirall, S.A. | Topical pharmaceutical compositions comprising a corticosteroid |
US11061751B2 (en) * | 2018-09-06 | 2021-07-13 | Micron Technology, Inc. | Providing bandwidth expansion for a memory sub-system including a sequencer separate from a controller |
US11080210B2 (en) | 2018-09-06 | 2021-08-03 | Micron Technology, Inc. | Memory sub-system including an in package sequencer separate from a controller |
RU2742411C1 (ru) * | 2020-10-08 | 2021-02-05 | Георгий Сергеевич Немов | Противопсориатическая косметическая композиция в виде геля |
RU2764574C1 (ru) * | 2020-10-16 | 2022-01-18 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук | Средство для лечения акне |
CA3211668A1 (en) * | 2021-03-16 | 2022-09-22 | Van Au | Cosmetic skin care composition |
EP4373526A1 (en) * | 2021-07-19 | 2024-05-29 | Excella Bioscientific Ltd | Compositions and uses of triglyceride mimetics to target selectively microbial lipase |
WO2023072954A1 (en) | 2021-10-25 | 2023-05-04 | Lipidor Ab | Topical cannabinoid compositions |
US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
DE10024413A1 (de) * | 2000-05-19 | 2001-12-06 | Mika Pharma Gmbh | Pharmazeutische und/oder kosmetische Zubereitung |
KR20020066778A (ko) * | 2001-02-13 | 2002-08-21 | 한국과학기술연구원 | 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법 |
JP2002308750A (ja) * | 2001-04-12 | 2002-10-23 | Lion Corp | 皮膚外用剤 |
FR2862540B1 (fr) * | 2003-11-21 | 2007-03-30 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
US20070196453A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
JP5137256B2 (ja) † | 2005-03-31 | 2013-02-06 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 皮膚効果剤の増強された送達 |
ZA200707487B (en) * | 2005-03-31 | 2008-12-31 | Unilever Plc | Enhanced delivery of skin benefit agents |
CN101370453B (zh) * | 2005-12-14 | 2013-12-18 | 努沃研究公司 | 用于皮肤输送药物的组合物和方法 |
EP1968541A2 (en) * | 2005-12-14 | 2008-09-17 | Zars, Inc. | Compositions and methods for dermal delivery of drugs |
JP5467722B2 (ja) * | 2007-01-16 | 2014-04-09 | ロート製薬株式会社 | 皮膚外用乳化製剤 |
CN101019833B (zh) * | 2007-02-16 | 2010-05-19 | 鲁传华 | 一种用作药物载体的药用油包油型非水微乳及其药物制剂 |
AU2008306317B2 (en) * | 2007-10-02 | 2012-04-26 | Lg Household & Health Care Ltd. | Cosmetic or pharmaceutical composition for topical application |
US9610463B2 (en) * | 2009-01-30 | 2017-04-04 | Beiersdorf Ag | Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex |
CA2779433A1 (en) | 2009-11-03 | 2011-05-12 | Lipidor Ab | Composition for promoting wound healing |
KR101748224B1 (ko) * | 2009-11-03 | 2017-06-16 | 리피도르 에이비 | 살아있는 유기체의 표면으로 투여하기 위한 지질층 형성 조성물 |
US20140073615A1 (en) * | 2011-05-02 | 2014-03-13 | Lipidor Ab | Treatment of Psoriasis |
CN113648278A (zh) * | 2013-05-03 | 2021-11-16 | 立普妥公司 | 用于给药的运载体和局部组合物 |
JP6563922B2 (ja) | 2013-11-14 | 2019-08-21 | リピドール エービー | ホスファチジルコリンを含む噴霧可能な局部用キャリアー及び組成物 |
-
2014
- 2014-11-06 JP JP2016528893A patent/JP6563922B2/ja active Active
- 2014-11-06 RU RU2016121389A patent/RU2699651C1/ru active
- 2014-11-06 WO PCT/SE2014/051313 patent/WO2015072909A1/en active Application Filing
- 2014-11-06 US US15/036,183 patent/US10034943B2/en active Active
- 2014-11-06 EP EP14861615.4A patent/EP3068437B2/en active Active
- 2014-11-06 KR KR1020167014035A patent/KR102297951B1/ko active IP Right Grant
- 2014-11-06 PL PL14861615.4T patent/PL3068437T5/pl unknown
- 2014-11-06 AU AU2014349256A patent/AU2014349256B2/en active Active
- 2014-11-06 HU HUE14861615A patent/HUE045492T2/hu unknown
- 2014-11-06 ES ES14861615T patent/ES2745093T5/es active Active
- 2014-11-06 CN CN202010951713.1A patent/CN112006989A/zh active Pending
- 2014-11-06 RS RS20191174A patent/RS59357B2/sr unknown
- 2014-11-06 EP EP19180857.5A patent/EP3610891A1/en not_active Withdrawn
- 2014-11-06 PT PT14861615T patent/PT3068437T/pt unknown
- 2014-11-06 CN CN201480062368.9A patent/CN105848684B/zh active Active
- 2014-11-06 DK DK14861615.4T patent/DK3068437T4/da active
- 2014-11-06 CA CA2929865A patent/CA2929865C/en active Active
-
2018
- 2018-07-06 US US16/028,691 patent/US10363314B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016537339A (ja) | 2016-12-01 |
EP3068437A4 (en) | 2017-04-05 |
ES2745093T5 (es) | 2022-11-10 |
AU2014349256B2 (en) | 2020-04-30 |
RS59357B1 (sr) | 2019-11-29 |
ES2745093T3 (es) | 2020-02-27 |
CA2929865C (en) | 2022-01-04 |
US20160303239A1 (en) | 2016-10-20 |
KR20160084409A (ko) | 2016-07-13 |
CA2929865A1 (en) | 2015-05-21 |
RU2699651C1 (ru) | 2019-09-09 |
EP3068437A1 (en) | 2016-09-21 |
RS59357B2 (sr) | 2022-11-30 |
US20170360937A9 (en) | 2017-12-21 |
CN105848684B (zh) | 2020-10-16 |
HUE045492T2 (hu) | 2019-12-30 |
US20180311360A1 (en) | 2018-11-01 |
AU2014349256A1 (en) | 2016-06-16 |
RU2016121389A (ru) | 2017-12-18 |
PL3068437T3 (pl) | 2020-03-31 |
CN105848684A (zh) | 2016-08-10 |
US10363314B2 (en) | 2019-07-30 |
EP3068437B1 (en) | 2019-06-19 |
KR102297951B1 (ko) | 2021-09-02 |
EP3610891A1 (en) | 2020-02-19 |
CN112006989A (zh) | 2020-12-01 |
PT3068437T (pt) | 2019-09-26 |
WO2015072909A1 (en) | 2015-05-21 |
JP6563922B2 (ja) | 2019-08-21 |
US10034943B2 (en) | 2018-07-31 |
EP3068437B2 (en) | 2022-07-06 |
DK3068437T4 (da) | 2022-09-26 |
PL3068437T5 (pl) | 2023-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3068437T3 (da) | Sprøjtbar topisk bærer og sammensætning omfattende phosphatidylcholin | |
DK3043784T3 (da) | Arylethere og anvendelser deraf | |
DK2970460T3 (da) | Anti-IL-33-antistoffer og anvendelser deraf | |
DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
DK2850202T3 (da) | Fremgangsmåder og grupper | |
CL2013001960S1 (es) | Audifonos | |
CL2013001961S1 (es) | Audifonos | |
HK1218576A1 (zh) | 結核病生物標誌物及其用途 | |
DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
FR3003076B1 (fr) | Supercondensateur electrochimique | |
DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
SG11201505760RA (en) | Speaker and speaker housing | |
EP2985314A4 (en) | CONTACT ELEMENT AND STRUCTURE CONTAINING THE CONTACT ELEMENT | |
BR112016003017A2 (pt) | Estrutura de suporte e transportador | |
DK3068428T3 (da) | Annexin-ii-variant-sammensætninger og fremgangsmåder | |
DK2983035T3 (da) | Faraday-rotator og lysisolator med faraday-rotator | |
FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
SG11201500034VA (en) | Static gel strength testing | |
GB201302971D0 (en) | Providing context in functional testing of web services | |
TR201313940A1 (tr) | Selüloz bazlı hamostatik ve antiseptik materyal | |
BR112015008704A2 (pt) | composição fungicida compreendendo mancozeb e clorotalonil | |
TH1401005077B (th) | วิธีการและเครื่องปลายทางสำหรับแสดงผลโปรแกรมเฉพาะงาน | |
GB201320632D0 (en) | Electrochemical cells and components thereof |